Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDGFRB | P09619 | 11/20 | 1.00 |
| ▸ | FGFR1 | P11362 | 11/20 | 1.00 |
| ▸ | KDR | P35968 | 11/20 | 1.00 |
| ▸ | ZAP70 | P43403 | 3/20 | 1.00 |
| ▸ | EGFR | P00533 | 4/20 | 0.78 |
| ▸ | SRC | P12931 | 1/20 | 0.73 |
| ▸ | FLT1 | P17948 | 3/20 | 0.70 |
| ▸ | AKT2 | P31751 | 1/20 | 0.69 |
| ▸ | AURKA | O14965 | 2/20 | 0.67 |
| ▸ | RET | P07949 | 2/20 | 0.67 |
| ▸ | FLT3 | P36888 | 2/20 | 0.67 |
| ▸ | MAP4K2 | Q12851 | 2/20 | 0.67 |
| ▸ | STK3 | Q13188 | 2/20 | 0.67 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.67 |
| ▸ | GAK | O14976 | 1/20 | 0.67 |
| ▸ | RPS6KA5 | O75582 | 1/20 | 0.67 |
| ▸ | RPS6KA4 | O75676 | 1/20 | 0.67 |
| ▸ | LATS1 | O95835 | 1/20 | 0.67 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.67 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6000887 | 1.00 | PDGFRB (1.00) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4407071 | 1.00 | PDGFRB (1.00) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL14519114 | 0.88 | PDGFRB (1.00) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4405755 | 0.88 | PDGFRB (1.00) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4405759 | 0.88 | PDGFRB (1.00) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4407137 | 0.87 | PDGFRB (0.81) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4407140 | 0.87 | PDGFRB (0.81) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4413149 | 0.86 | PDGFRB (0.77) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4414661 | 0.86 | PDGFRB (0.80) | PDGFRBFGFR1KDRZAP70EGFR | |
| SCHEMBL4414657 | 0.86 | PDGFRB (0.80) | PDGFRBFGFR1KDRZAP70EGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030105151-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | SUGEN, INC. | 2003-06-05 | — | — | US | claimed |
| EP-2020408-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | Sugen, Inc. (US) | 2009-02-04 | — | — | EP | disclosed |
| EP-1975620-A2 | Three hybrid assay system | GPC Biotech AG (DE) | 2008-10-01 | — | — | EP | disclosed |
| US-7211600-B2 | Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds | SUGEN INC. (US) | 2007-05-01 | — | — | US | disclosed |
| US-7211600-B2 | Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds | SUGEN INC. (US) | 2007-05-01 | — | — | US | disclosed |
| US-6878733-B1 | Formulations for pharmaceutical agents ionizable as free acids or free bases | SUGEN, INC. (US) | 2005-04-12 | — | — | US | disclosed |
| US-6846839-B1 | Methods for treating diseases and disorders related to unregulated angiogenesis and/or vasculogenesis | SUGEN, INC. (US) | 2005-01-25 | — | — | US | disclosed |
| US-20030105151-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | SUGEN, INC. | 2003-06-05 | — | — | US | disclosed |
| US-6395734-B1 | ANTICANCER AGENTS | SUGEN, INC. | 2002-05-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105151-A1 | Pyrrole substituted 2-indolinone protein kinase inhibitors | DMPK, PDPK1, PLK2 | PDGFRB 1086/4885FGFR1 930/4885KDR 1066/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.